Found 9 matching trials
A Pan-TB Regimen Targeting Host and Microbe PHASE2 This project will develop the first regimen meeting WHO criteria for a pan-...
Show More Status
Active Not Recruiting
Location
Instituto Nacional de Saúde
Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics And Measurement Of Whole Blood Activity (WBA) Of PNU-100480 After Multiple Oral Doses In Healthy Adult Volunteers PHASE1 The purpose of this study is to assess the safety, tolerability and pharmac...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay PHASE2 PNU-100480 is being developed for the treatment of both drug resistant and ...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
The Individualized M(X) Drug-resistant TB Treatment Strategy Study PHASE4 This is a randomized controlled clinical trial comparing treatment success ...
Show More Location
King Dinuzulu Hospital
Learn More & Join Trial
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid PHASE1 This is a randomized, double-blind, placebo-controlled, single ascending do...
Show More Location
Worldwide Clinical Trials
Learn More & Join Trial
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis PHASE2 A5409/RAD-TB is an adaptive Phase 2 randomized, controlled, open-label, dos...
Show More Location
12701, Gaborone CRS
Learn More & Join Trial
PanACEA Sutezolid Dose-finding and Combination Evaluation PHASE2 This study is an open-label, randomized, controlled, multi-center Phase IIB...
Show More Location
The Aurum Institute for Health Research
Learn More & Join Trial
Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy Adults PHASE1 The purpose of this study is to evaluate the safety, tolerability, and phar...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis PHASE2 This multicenter, two-stage, open-label, randomized trial will aim to asses...
Show More Location
Tropical Disease Foundation
Treatments Being Tested
Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS) Pretomanid, Bedaquiline, OPC-167832, and Sutezolid (PBOS) Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (HRZE) Pretomanid or Delamanid, Bedaquiline, OPC-167832, and Sutezolid (XBOS) Isoniazid and Rifampicin (HR) Learn More & Join Trial